Confirm shipping costs for smaller tiers and - critically - confirm the return contact channel before you commit to any order size
Tirzepatide's GIP receptor activation adds a second hormone pathway that enhances satiety and energy expenditure beyond what GLP-1 alone provides
Phentermine has a much shorter half-life and wears off within several hours
Contact your healthcare provider if you experience: Bruises larger than two inches in diameter or that continue expanding after 24 hours Severe pain at the injection site that interferes with daily activities or doesn't improve within 48 hours Signs of infection including increasing warmth, redness spreading beyond the immediate injection site, purulent drainage, or fever above 100.4F (38C) Bruising that persists beyond three weeks without improvement Development of a hard lump or nodule beneath the skin that doesn't resolve Sudden increase in bruising frequency or severity compared to your usual pattern Bruising accompanied by unusual bleeding from other sites (gums, nose, or in urine/stool) Patients taking anticoagulant medications require particular vigilance
On April 1, 2026, the FDA approved Eli Lillys FOUNDAYO (orforglipron) , the second oral GLP-1 approved for obesity, and arguably the one with the more patient-friendly convenience profile
